Identification of prognostic different subgroups in triple negative breast cancer by Her2-neu protein expression.

about

Prognostic Value of E-Cadherin and β-Catenin in Triple-Negative Breast Cancer.Loss of Anti-HER-3 CD4+ T-Helper Type 1 Immunity Occurs in Breast Tumorigenesis and is Negatively Associated with Outcomes.Her2-neu score as a prognostic factor for outcome in patients with triple-negative breast cancer.

P2860

Q50560631-49E39FD2-9D27-4DCD-97D4-A1EAFE8697BE Q52909381-410A7031-DD23-41F1-8304-2CC9F134728E Q54110141-8D3B626D-D64C-465D-AE61-5521F9BC0E3C

P2860

Identification of prognostic different subgroups in triple negative breast cancer by Her2-neu protein expression.

Item

http://www.wikidata.org/entity/Q50658602

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Identification of prognostic d ...... y Her2-neu protein expression.

@en

Identification of prognostic d ...... y Her2-neu protein expression.

@nl

type

Item

label

Identification of prognostic d ...... y Her2-neu protein expression.

@en

Identification of prognostic d ...... y Her2-neu protein expression.

@nl

prefLabel

Identification of prognostic d ...... y Her2-neu protein expression.

@en

Identification of prognostic d ...... y Her2-neu protein expression.

@nl

P1476

Identification of prognostic d ...... y Her2-neu protein expression.

@en

P2093

Achim Rody

http://www.w3.org/2001/XMLSchema#string

Cornelia Liedtke

http://www.w3.org/2001/XMLSchema#string

Daniel Herr

http://www.w3.org/2001/XMLSchema#string

Erich-Franz Solomayer

http://www.w3.org/2001/XMLSchema#string

Gilda Schmidt

http://www.w3.org/2001/XMLSchema#string

Ingolf Juhasz-Böss

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNAs and triple negative breast cancer

The Ki-67 protein: from the known and the unknown

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

Triple-negative breast cancer: an unmet medical need

Triple-Negative Breast Cancer

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

The ErbB signaling network: receptor heterodimerization in development and cancer

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer.

P2888

s00404-014-3331-4

P304

1221-1229

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00404-014-3331-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

290

http://www.w3.org/2001/XMLSchema#string

P50

Christoph Gerlinger

Gabriele Meyberg-Solomayer

P577

2014-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25012601

http://www.w3.org/2001/XMLSchema#string

Identification of prognostic different subgroups in triple negative breast cancer by Her2-neu protein expression.

about

P2860

P2860

Identification of prognostic different subgroups in triple negative breast cancer by Her2-neu protein expression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698